Nuformix operates a semi-virtual business model that maximises efficiency of investment.
Low Fixed Costs
Small in-house team maintains low fixed costs.
Ownership of key cocrystal technology R&D stages leveraging low-cost external development services for common steps.
Access to External Experts
Global network of specialists and KOL’s is custom-built to validate and advance our programmes when required.
Our development partnerships enable us to share risk and costs yet are targeted to increase our internal knowledge base.
Optionality within our clinical programmes promotes achievement of commercial objectives.
Ability to rapidly adapt R&D to emerging disease and market landscape.